

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.41741309 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.97201455 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.96070311 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.96070311 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.96070311 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.96070311 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.96070311 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.96070311 |
| 9 | respiratory burst (GO:0045730) | 5.89679583 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.56821648 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.41407436 |
| 12 | neutrophil mediated immunity (GO:0002446) | 5.17058257 |
| 13 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.09062269 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.97305356 |
| 15 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.88464188 |
| 16 | negative regulation of phagocytosis (GO:0050765) | 4.58448202 |
| 17 | response to peptidoglycan (GO:0032494) | 4.57892590 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.55481180 |
| 19 | neutrophil activation (GO:0042119) | 4.38018582 |
| 20 | reactive oxygen species biosynthetic process (GO:1903409) | 4.37787918 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.26869253 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 4.24026610 |
| 23 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.22776780 |
| 24 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17938414 |
| 25 | response to host immune response (GO:0052572) | 4.17938414 |
| 26 | pinocytosis (GO:0006907) | 4.17676303 |
| 27 | granulocyte activation (GO:0036230) | 4.15735319 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13970837 |
| 29 | response to fungus (GO:0009620) | 4.12792850 |
| 30 | detection of other organism (GO:0098543) | 4.12628429 |
| 31 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.10792358 |
| 32 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.10792358 |
| 33 | myeloid cell activation involved in immune response (GO:0002275) | 4.10363195 |
| 34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.07526817 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 4.05160647 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.01005517 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.01005517 |
| 38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98888615 |
| 39 | regulation of interferon-alpha production (GO:0032647) | 3.98495059 |
| 40 | myeloid leukocyte mediated immunity (GO:0002444) | 3.95614219 |
| 41 | detection of molecule of bacterial origin (GO:0032490) | 3.93272251 |
| 42 | regulation of mast cell activation (GO:0033003) | 3.91826399 |
| 43 | regulation of mast cell degranulation (GO:0043304) | 3.87144750 |
| 44 | detection of bacterium (GO:0016045) | 3.80255378 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.80178875 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.77659575 |
| 47 | response to host (GO:0075136) | 3.77659575 |
| 48 | response to host defenses (GO:0052200) | 3.77659575 |
| 49 | leukocyte mediated cytotoxicity (GO:0001909) | 3.77622945 |
| 50 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.77245454 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.72691008 |
| 52 | superoxide anion generation (GO:0042554) | 3.72030298 |
| 53 | leukocyte aggregation (GO:0070486) | 3.71983225 |
| 54 | detection of external biotic stimulus (GO:0098581) | 3.70027706 |
| 55 | B cell mediated immunity (GO:0019724) | 3.67579370 |
| 56 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.66151541 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65184339 |
| 58 | defense response to fungus (GO:0050832) | 3.64411481 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59563810 |
| 60 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.57806565 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 3.56435370 |
| 62 | mast cell activation (GO:0045576) | 3.56407420 |
| 63 | cellular response to zinc ion (GO:0071294) | 3.55069869 |
| 64 | cellular extravasation (GO:0045123) | 3.48683006 |
| 65 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.48298840 |
| 66 | microglial cell activation (GO:0001774) | 3.46055174 |
| 67 | cellular response to interleukin-15 (GO:0071350) | 3.45940725 |
| 68 | response to interleukin-15 (GO:0070672) | 3.43067339 |
| 69 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.42096628 |
| 70 | regulation of growth of symbiont in host (GO:0044126) | 3.42096628 |
| 71 | negative regulation of growth of symbiont in host (GO:0044130) | 3.42096628 |
| 72 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.42096628 |
| 73 | negative regulation of mast cell activation (GO:0033004) | 3.42046241 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 3.42027376 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 3.39328954 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.35767751 |
| 77 | positive regulation of mast cell degranulation (GO:0043306) | 3.35767751 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.34193419 |
| 79 | macrophage activation (GO:0042116) | 3.33683110 |
| 80 | regulation of B cell differentiation (GO:0045577) | 3.33482081 |
| 81 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.31197023 |
| 82 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.28748331 |
| 83 | detection of biotic stimulus (GO:0009595) | 3.28135781 |
| 84 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.27484883 |
| 85 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.26953117 |
| 86 | activated T cell proliferation (GO:0050798) | 3.24463766 |
| 87 | actin nucleation (GO:0045010) | 3.24292232 |
| 88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.23853558 |
| 89 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.19806010 |
| 90 | defense response to protozoan (GO:0042832) | 3.19588710 |
| 91 | phagosome maturation (GO:0090382) | 3.16682493 |
| 92 | negative thymic T cell selection (GO:0045060) | 3.16220616 |
| 93 | negative T cell selection (GO:0043383) | 3.15486852 |
| 94 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.13746748 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12545464 |
| 96 | leukotriene metabolic process (GO:0006691) | 3.11860709 |
| 97 | interferon-gamma production (GO:0032609) | 3.09763543 |
| 98 | myeloid leukocyte activation (GO:0002274) | 3.09705489 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.08670911 |
| 100 | leukocyte degranulation (GO:0043299) | 3.08514651 |
| 101 | DNA deamination (GO:0045006) | 3.03234428 |
| 102 | neutrophil chemotaxis (GO:0030593) | 2.97745899 |
| 103 | disruption of cells of other organism (GO:0044364) | 2.97363529 |
| 104 | killing of cells of other organism (GO:0031640) | 2.97363529 |
| 105 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.94989882 |
| 106 | positive regulation of interferon-beta production (GO:0032728) | 2.94029719 |
| 107 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.93885710 |
| 108 | B cell receptor signaling pathway (GO:0050853) | 2.93575026 |
| 109 | response to protozoan (GO:0001562) | 2.92898457 |
| 110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.91868119 |
| 111 | response to type I interferon (GO:0034340) | 2.91285534 |
| 112 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.90325902 |
| 113 | type I interferon signaling pathway (GO:0060337) | 2.89767421 |
| 114 | cellular response to type I interferon (GO:0071357) | 2.89767421 |
| 115 | neutrophil migration (GO:1990266) | 2.89073518 |
| 116 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87916608 |
| 117 | negative regulation of interleukin-17 production (GO:0032700) | 2.87306837 |
| 118 | positive thymic T cell selection (GO:0045059) | 2.87189356 |
| 119 | myeloid dendritic cell activation (GO:0001773) | 2.86963749 |
| 120 | macrophage differentiation (GO:0030225) | 2.86614042 |
| 121 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86341240 |
| 122 | mast cell activation involved in immune response (GO:0002279) | 2.86320574 |
| 123 | mast cell degranulation (GO:0043303) | 2.86320574 |
| 124 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.86319350 |
| 125 | angiogenesis involved in wound healing (GO:0060055) | 2.84634219 |
| 126 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.84149444 |
| 127 | leukocyte mediated immunity (GO:0002443) | 2.83457025 |
| 128 | positive regulation of leukocyte degranulation (GO:0043302) | 2.82172404 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.81840155 |
| 130 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.81719411 |
| 131 | negative regulation of cell killing (GO:0031342) | 2.80951686 |
| 132 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80951686 |
| 133 | dendritic cell differentiation (GO:0097028) | 2.80833999 |
| 134 | natural killer cell mediated immunity (GO:0002228) | 2.80658014 |
| 135 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.80658014 |
| 136 | negative regulation of innate immune response (GO:0045824) | 2.80498539 |
| 137 | negative regulation of granulocyte differentiation (GO:0030853) | 2.80053583 |
| 138 | negative regulation of interleukin-1 production (GO:0032692) | 2.79118866 |
| 139 | negative regulation of adaptive immune response (GO:0002820) | 2.78471931 |
| 140 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.78281262 |
| 141 | response to interferon-beta (GO:0035456) | 2.78263585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.61743431 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.63643800 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.63431141 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.58208987 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.79687209 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.78540961 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72442456 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71863897 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40147576 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14906166 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.99571152 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85848397 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.78306386 |
| 14 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.72507534 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65521308 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.64072043 |
| 17 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.63610672 |
| 18 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.60568572 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.54920128 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54065441 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.39693852 |
| 22 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.23706384 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23174739 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17966311 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17059791 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12685942 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11153570 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02894199 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.96433310 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.93289681 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89307063 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.88471362 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.88091737 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86816230 |
| 35 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79121399 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.75015838 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.74057182 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73743117 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.68851151 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.68349587 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67064062 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65883318 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64747778 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57891124 |
| 45 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56793640 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53823854 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.51829324 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50289313 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48719195 |
| 50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.48603900 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47321171 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46956956 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43896018 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42915317 |
| 55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42300120 |
| 56 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41915295 |
| 57 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40832283 |
| 58 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38607591 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35902399 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34646242 |
| 61 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34258870 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32651151 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32085624 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.31276450 |
| 65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30957330 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30437492 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28916752 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24839332 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22805978 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22277416 |
| 71 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.20845687 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18962031 |
| 73 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.18679532 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18565568 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15353680 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14437720 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12711663 |
| 78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10885778 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09806484 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08822723 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08791898 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04932076 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02678742 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00790368 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99211477 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97848254 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 0.97116199 |
| 88 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96775605 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96269626 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96253075 |
| 91 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95114355 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94868693 |
| 93 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94318372 |
| 94 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93349879 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93043407 |
| 96 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.92815425 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92663773 |
| 98 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92445060 |
| 99 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91988260 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91470080 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90527709 |
| 102 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90488715 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90474715 |
| 104 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89885456 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89263788 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89137742 |
| 107 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88983010 |
| 108 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87885259 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87014373 |
| 110 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86863581 |
| 111 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.86554390 |
| 112 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86517679 |
| 113 | P300_27268052_Chip-Seq_Bcells_Human | 0.84317047 |
| 114 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84254276 |
| 115 | VDR_22108803_ChIP-Seq_LS180_Human | 0.83582915 |
| 116 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83093327 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81538763 |
| 118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80903789 |
| 119 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.80058262 |
| 120 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.79934682 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78432990 |
| 122 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77719968 |
| 123 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.77054047 |
| 124 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.76430442 |
| 125 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75050146 |
| 126 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.74721980 |
| 127 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.73364703 |
| 128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72964308 |
| 129 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72127129 |
| 130 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.71921309 |
| 131 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.71898982 |
| 132 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.71189379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.26750395 |
| 2 | MP0003436_decreased_susceptibility_to | 3.97632446 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.93106202 |
| 4 | MP0003303_peritoneal_inflammation | 3.47508508 |
| 5 | MP0002419_abnormal_innate_immunity | 3.37958730 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.27086991 |
| 7 | MP0009785_altered_susceptibility_to | 3.02729493 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.93561281 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.82517154 |
| 10 | MP0005025_abnormal_response_to | 2.80297114 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.56131634 |
| 12 | MP0006082_CNS_inflammation | 2.54493178 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.42943820 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.32045517 |
| 15 | MP0002723_abnormal_immune_serum | 2.30324539 |
| 16 | MP0001819_abnormal_immune_cell | 2.29919334 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.29873527 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.26479736 |
| 19 | MP0001800_abnormal_humoral_immune | 2.26226080 |
| 20 | MP0005174_abnormal_tail_pigmentation | 2.20591800 |
| 21 | MP0001790_abnormal_immune_system | 2.20392481 |
| 22 | MP0005387_immune_system_phenotype | 2.20392481 |
| 23 | MP0003724_increased_susceptibility_to | 2.18584038 |
| 24 | MP0000685_abnormal_immune_system | 2.18156251 |
| 25 | MP0005671_abnormal_response_to | 2.08636225 |
| 26 | MP0001853_heart_inflammation | 2.03634999 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.01355296 |
| 28 | MP0002405_respiratory_system_inflammati | 2.01031047 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.96251194 |
| 30 | MP0009840_abnormal_foam_cell | 1.93159642 |
| 31 | MP0000343_altered_response_to | 1.91412474 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.82147393 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.78997600 |
| 34 | MP0000716_abnormal_immune_system | 1.76471152 |
| 35 | MP0002398_abnormal_bone_marrow | 1.73564012 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.73180024 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.73180024 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.69218117 |
| 39 | MP0004510_myositis | 1.67717577 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.65001503 |
| 41 | MP0000858_altered_metastatic_potential | 1.61489137 |
| 42 | MP0010307_abnormal_tumor_latency | 1.61282736 |
| 43 | MP0008469_abnormal_protein_level | 1.56446533 |
| 44 | MP0009278_abnormal_bone_marrow | 1.56237882 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.55886668 |
| 46 | MP0002429_abnormal_blood_cell | 1.52725234 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.51025658 |
| 48 | MP0003448_altered_tumor_morphology | 1.50700974 |
| 49 | MP0003075_altered_response_to | 1.50045909 |
| 50 | MP0002722_abnormal_immune_system | 1.47549219 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.43070980 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.41506116 |
| 53 | MP0003195_calcinosis | 1.41293894 |
| 54 | MP0002006_tumorigenesis | 1.40016791 |
| 55 | MP0005310_abnormal_salivary_gland | 1.39124550 |
| 56 | MP0003787_abnormal_imprinting | 1.37203506 |
| 57 | MP0000490_abnormal_crypts_of | 1.36317813 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.33409989 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.33193772 |
| 60 | MP0002132_abnormal_respiratory_system | 1.28886961 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.28485430 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.26223227 |
| 63 | MP0001986_abnormal_taste_sensitivity | 1.25892780 |
| 64 | MP0000604_amyloidosis | 1.25798092 |
| 65 | MP0002653_abnormal_ependyma_morphology | 1.24298905 |
| 66 | MP0003690_abnormal_glial_cell | 1.23891562 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.18832821 |
| 68 | MP0001851_eye_inflammation | 1.15421031 |
| 69 | MP0009764_decreased_sensitivity_to | 1.15004754 |
| 70 | MP0004947_skin_inflammation | 1.14134095 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.13925651 |
| 72 | MP0004381_abnormal_hair_follicle | 1.12554341 |
| 73 | MP0001873_stomach_inflammation | 1.12178303 |
| 74 | MP0003186_abnormal_redox_activity | 1.10313846 |
| 75 | MP0005166_decreased_susceptibility_to | 1.07904912 |
| 76 | MP0002933_joint_inflammation | 1.07639660 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 1.01640510 |
| 78 | MP0002095_abnormal_skin_pigmentation | 0.92385270 |
| 79 | MP0008260_abnormal_autophagy | 0.92288413 |
| 80 | MP0005257_abnormal_intraocular_pressure | 0.91079343 |
| 81 | MP0003828_pulmonary_edema | 0.91034351 |
| 82 | MP0005390_skeleton_phenotype | 0.89547554 |
| 83 | MP0003646_muscle_fatigue | 0.88193632 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.87158749 |
| 85 | MP0003693_abnormal_embryo_hatching | 0.84922878 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.84905134 |
| 87 | MP0003566_abnormal_cell_adhesion | 0.84833359 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.84149683 |
| 89 | MP0009763_increased_sensitivity_to | 0.82120083 |
| 90 | MP0003866_abnormal_defecation | 0.81638978 |
| 91 | MP0002019_abnormal_tumor_incidence | 0.80851383 |
| 92 | MP0005164_abnormal_response_to | 0.78326915 |
| 93 | MP0000371_diluted_coat_color | 0.77979788 |
| 94 | MP0001663_abnormal_digestive_system | 0.77338728 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.76251566 |
| 96 | MP0000249_abnormal_blood_vessel | 0.76164271 |
| 97 | MP0003795_abnormal_bone_structure | 0.73333746 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.71988720 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.71650518 |
| 100 | MP0003878_abnormal_ear_physiology | 0.70606376 |
| 101 | MP0005377_hearing/vestibular/ear_phenot | 0.70606376 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.70294555 |
| 103 | MP0002928_abnormal_bile_duct | 0.69521572 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.67237368 |
| 105 | MP0010094_abnormal_chromosome_stability | 0.65158315 |
| 106 | MP0008873_increased_physiological_sensi | 0.64711610 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.64599405 |
| 108 | MP0006054_spinal_hemorrhage | 0.64257424 |
| 109 | MP0004883_abnormal_blood_vessel | 0.62308710 |
| 110 | MP0000920_abnormal_myelination | 0.61689603 |
| 111 | MP0000598_abnormal_liver_morphology | 0.60810686 |
| 112 | MP0000313_abnormal_cell_death | 0.57942984 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.55638686 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.55318584 |
| 115 | MP0003077_abnormal_cell_cycle | 0.53925366 |
| 116 | MP0004130_abnormal_muscle_cell | 0.53859873 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.53534955 |
| 118 | MP0000372_irregular_coat_pigmentation | 0.53119828 |
| 119 | MP0003111_abnormal_nucleus_morphology | 0.52510383 |
| 120 | MP0003045_fibrosis | 0.51488273 |
| 121 | MP0000609_abnormal_liver_physiology | 0.50882376 |
| 122 | MP0008872_abnormal_physiological_respon | 0.49219447 |
| 123 | MP0004742_abnormal_vestibular_system | 0.48907800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.55766045 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.95091729 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.73789484 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.00675604 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.81530240 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.38215100 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.35050269 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.23646834 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.86290846 |
| 10 | Obstructive lung disease (HP:0006536) | 4.86290846 |
| 11 | Myositis (HP:0100614) | 4.31649734 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.10181240 |
| 13 | Dysostosis multiplex (HP:0000943) | 4.09164781 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.06160306 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 4.01953927 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.01953927 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.01953927 |
| 18 | Recurrent skin infections (HP:0001581) | 3.92740103 |
| 19 | Gingivitis (HP:0000230) | 3.86285491 |
| 20 | Disinhibition (HP:0000734) | 3.69011192 |
| 21 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.66313152 |
| 22 | Encephalitis (HP:0002383) | 3.65805209 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.62161788 |
| 24 | Agnosia (HP:0010524) | 3.56088037 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.53173303 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.53173303 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.47567673 |
| 28 | Axonal loss (HP:0003447) | 3.44666307 |
| 29 | Keratoconjunctivitis (HP:0001096) | 3.40383571 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 3.35648236 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.31890672 |
| 32 | Abnormality of T cell number (HP:0011839) | 3.30713895 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.29381861 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.29381861 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.29381861 |
| 36 | T lymphocytopenia (HP:0005403) | 3.25136826 |
| 37 | Orchitis (HP:0100796) | 3.24063118 |
| 38 | Cellulitis (HP:0100658) | 3.23805555 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 3.09001207 |
| 40 | Loss of speech (HP:0002371) | 3.06266476 |
| 41 | Thrombocytosis (HP:0001894) | 3.05118700 |
| 42 | Stomatitis (HP:0010280) | 3.01597797 |
| 43 | Meningitis (HP:0001287) | 3.00625407 |
| 44 | Abnormality of T cells (HP:0002843) | 2.93660684 |
| 45 | Urticaria (HP:0001025) | 2.85269117 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.81721110 |
| 47 | Periodontitis (HP:0000704) | 2.79866862 |
| 48 | J-shaped sella turcica (HP:0002680) | 2.79725284 |
| 49 | Agammaglobulinemia (HP:0004432) | 2.78765973 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.77640308 |
| 51 | Chronic otitis media (HP:0000389) | 2.73232863 |
| 52 | Recurrent viral infections (HP:0004429) | 2.73215132 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.72586436 |
| 54 | Petechiae (HP:0000967) | 2.71966664 |
| 55 | Optic neuritis (HP:0100653) | 2.67020901 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.67020901 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.64766794 |
| 58 | Osteomyelitis (HP:0002754) | 2.61096911 |
| 59 | Abnormality of B cell number (HP:0010975) | 2.60831798 |
| 60 | IgM deficiency (HP:0002850) | 2.60543518 |
| 61 | Anorexia (HP:0002039) | 2.56030055 |
| 62 | Thoracic kyphosis (HP:0002942) | 2.53131339 |
| 63 | Hypochromic anemia (HP:0001931) | 2.51264219 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.50588466 |
| 65 | Increased IgM level (HP:0003496) | 2.50474316 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.47685011 |
| 67 | Abnormality of eosinophils (HP:0001879) | 2.47500673 |
| 68 | Stomach cancer (HP:0012126) | 2.47036241 |
| 69 | Recurrent pneumonia (HP:0006532) | 2.46974028 |
| 70 | Basal ganglia calcification (HP:0002135) | 2.45933612 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.44838573 |
| 72 | Episodic fever (HP:0001954) | 2.44643294 |
| 73 | Severe combined immunodeficiency (HP:0004430) | 2.43089188 |
| 74 | Vasculitis (HP:0002633) | 2.41176341 |
| 75 | Pustule (HP:0200039) | 2.41066975 |
| 76 | Papilledema (HP:0001085) | 2.39692872 |
| 77 | Increased IgE level (HP:0003212) | 2.39685427 |
| 78 | IgG deficiency (HP:0004315) | 2.39633184 |
| 79 | Thyroiditis (HP:0100646) | 2.32630263 |
| 80 | Pulmonary embolism (HP:0002204) | 2.29251448 |
| 81 | Glomerulonephritis (HP:0000099) | 2.28769817 |
| 82 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.25029509 |
| 83 | Abnormality of the lumbar spine (HP:0100712) | 2.23127096 |
| 84 | Abnormality of the prostate (HP:0008775) | 2.19612165 |
| 85 | Albinism (HP:0001022) | 2.17564844 |
| 86 | Abnormality of the thoracic spine (HP:0100711) | 2.16664465 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.16476522 |
| 88 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.14340541 |
| 89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.14340541 |
| 90 | Diminished motivation (HP:0000745) | 2.14186730 |
| 91 | Sepsis (HP:0100806) | 2.13774676 |
| 92 | Recurrent bronchitis (HP:0002837) | 2.12970592 |
| 93 | Epistaxis (HP:0000421) | 2.12383871 |
| 94 | B lymphocytopenia (HP:0010976) | 2.12290760 |
| 95 | Gangrene (HP:0100758) | 2.11596470 |
| 96 | Hemoptysis (HP:0002105) | 2.10456543 |
| 97 | Leukocytosis (HP:0001974) | 2.10233727 |
| 98 | Microcytic anemia (HP:0001935) | 2.10155706 |
| 99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08067219 |
| 100 | Pathologic fracture (HP:0002756) | 2.05685422 |
| 101 | Chest pain (HP:0100749) | 2.04151363 |
| 102 | Joint hemorrhage (HP:0005261) | 2.03505185 |
| 103 | Autoimmune hemolytic anemia (HP:0001890) | 2.02648664 |
| 104 | Prolonged bleeding time (HP:0003010) | 2.01507406 |
| 105 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01157048 |
| 106 | Poor head control (HP:0002421) | 2.01027457 |
| 107 | Inflammation of the large intestine (HP:0002037) | 1.99046223 |
| 108 | Reduced antithrombin III activity (HP:0001976) | 1.98107768 |
| 109 | Vertigo (HP:0002321) | 1.97840859 |
| 110 | Keratitis (HP:0000491) | 1.97691517 |
| 111 | Hematochezia (HP:0002573) | 1.97371516 |
| 112 | Recurrent sinusitis (HP:0011108) | 1.97322732 |
| 113 | Combined immunodeficiency (HP:0005387) | 1.96876485 |
| 114 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.95590307 |
| 115 | Lymphopenia (HP:0001888) | 1.95385044 |
| 116 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95354125 |
| 117 | Congenital stationary night blindness (HP:0007642) | 1.92701798 |
| 118 | Eosinophilia (HP:0001880) | 1.92564525 |
| 119 | Polyneuropathy (HP:0001271) | 1.92541866 |
| 120 | Abnormal platelet function (HP:0011869) | 1.90916553 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.90916553 |
| 122 | Progressive neurologic deterioration (HP:0002344) | 1.89969570 |
| 123 | Deformed sella turcica (HP:0002681) | 1.89717104 |
| 124 | Apathy (HP:0000741) | 1.89341960 |
| 125 | Skin ulcer (HP:0200042) | 1.88815104 |
| 126 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.88749695 |
| 127 | Gingival bleeding (HP:0000225) | 1.87953413 |
| 128 | Inappropriate behavior (HP:0000719) | 1.86856520 |
| 129 | Skin rash (HP:0000988) | 1.86336031 |
| 130 | Gastrointestinal inflammation (HP:0004386) | 1.86048973 |
| 131 | Arterial thrombosis (HP:0004420) | 1.84700567 |
| 132 | Keratoconjunctivitis sicca (HP:0001097) | 1.84081224 |
| 133 | Attenuation of retinal blood vessels (HP:0007843) | 1.83564624 |
| 134 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82365506 |
| 135 | Abnormality of the pleura (HP:0002103) | 1.80742770 |
| 136 | Granulocytopenia (HP:0001913) | 1.80477935 |
| 137 | Personality changes (HP:0000751) | 1.80404133 |
| 138 | Prostate neoplasm (HP:0100787) | 1.80216240 |
| 139 | Abnormality of the endocardium (HP:0004306) | 1.76958419 |
| 140 | Hypergammaglobulinemia (HP:0010702) | 1.76841247 |
| 141 | Abnormality of T cell physiology (HP:0011840) | 1.73696429 |
| 142 | Myocardial infarction (HP:0001658) | 1.73386807 |
| 143 | Nasal polyposis (HP:0100582) | 1.70667579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.00051751 |
| 2 | KIT | 3.72627315 |
| 3 | BLK | 3.34653787 |
| 4 | MAP4K1 | 3.16901900 |
| 5 | RIPK4 | 2.98457827 |
| 6 | FRK | 2.77887047 |
| 7 | ERN1 | 2.52748551 |
| 8 | TBK1 | 2.45744708 |
| 9 | TYK2 | 2.37483848 |
| 10 | BTK | 2.17284772 |
| 11 | FES | 2.14889419 |
| 12 | TEC | 2.13246035 |
| 13 | CSF1R | 2.03509097 |
| 14 | TNK2 | 1.98969144 |
| 15 | PIM2 | 1.80939337 |
| 16 | NME2 | 1.77244473 |
| 17 | MAP3K14 | 1.77014384 |
| 18 | TAOK3 | 1.76672609 |
| 19 | TGFBR2 | 1.72912478 |
| 20 | SYK | 1.72370806 |
| 21 | MAP2K3 | 1.69880914 |
| 22 | CLK1 | 1.64997604 |
| 23 | IRAK3 | 1.60641572 |
| 24 | IKBKE | 1.60563573 |
| 25 | FLT3 | 1.57971631 |
| 26 | PKN2 | 1.57657924 |
| 27 | MAP3K12 | 1.46995048 |
| 28 | ZAP70 | 1.46400116 |
| 29 | HCK | 1.46184511 |
| 30 | LYN | 1.40392970 |
| 31 | IKBKB | 1.37971315 |
| 32 | STK10 | 1.37907329 |
| 33 | TXK | 1.34257446 |
| 34 | SCYL2 | 1.33307432 |
| 35 | CSK | 1.31446023 |
| 36 | NEK9 | 1.31037816 |
| 37 | NUAK1 | 1.31004236 |
| 38 | JAK1 | 1.24109664 |
| 39 | MATK | 1.22956191 |
| 40 | PINK1 | 1.22592074 |
| 41 | PBK | 1.21981221 |
| 42 | ITK | 1.21485833 |
| 43 | PAK4 | 1.20646242 |
| 44 | TESK2 | 1.19404857 |
| 45 | TLK1 | 1.19072506 |
| 46 | MAP4K2 | 1.18046730 |
| 47 | IRAK1 | 1.16728480 |
| 48 | BCKDK | 1.16722124 |
| 49 | GRK6 | 1.16460870 |
| 50 | BMPR1B | 1.13020875 |
| 51 | CAMKK2 | 1.12287716 |
| 52 | JAK3 | 1.09837920 |
| 53 | LCK | 1.06316262 |
| 54 | EIF2AK3 | 1.05405687 |
| 55 | TRPM7 | 1.05220163 |
| 56 | PIM1 | 1.05161118 |
| 57 | LRRK2 | 1.03524564 |
| 58 | ABL2 | 1.03395876 |
| 59 | GRK1 | 1.02406471 |
| 60 | MAP2K6 | 1.00954215 |
| 61 | STK4 | 1.00855936 |
| 62 | PRKCQ | 0.99745138 |
| 63 | EPHB1 | 0.99042821 |
| 64 | DAPK2 | 0.98831572 |
| 65 | CDK19 | 0.94295462 |
| 66 | BMPR2 | 0.89601390 |
| 67 | RPS6KA4 | 0.88528088 |
| 68 | TESK1 | 0.87608870 |
| 69 | OXSR1 | 0.84713255 |
| 70 | JAK2 | 0.81791225 |
| 71 | MAP3K13 | 0.78755312 |
| 72 | TRIB3 | 0.77276451 |
| 73 | PTK2B | 0.76182612 |
| 74 | ZAK | 0.75904998 |
| 75 | PRKCD | 0.74150217 |
| 76 | RPS6KA6 | 0.73696817 |
| 77 | FGR | 0.72431817 |
| 78 | NEK2 | 0.71409078 |
| 79 | CDK6 | 0.71147004 |
| 80 | TAOK1 | 0.70736035 |
| 81 | MAP3K11 | 0.70416366 |
| 82 | WEE1 | 0.69107338 |
| 83 | CDC7 | 0.67820456 |
| 84 | RPS6KC1 | 0.67700343 |
| 85 | RPS6KL1 | 0.67700343 |
| 86 | KDR | 0.66902875 |
| 87 | STK16 | 0.62926922 |
| 88 | DAPK1 | 0.60334819 |
| 89 | WNK3 | 0.59603274 |
| 90 | TTN | 0.59263853 |
| 91 | MAPK4 | 0.57977731 |
| 92 | CAMKK1 | 0.57960726 |
| 93 | SIK2 | 0.57488575 |
| 94 | MARK3 | 0.57298460 |
| 95 | EPHA3 | 0.56651291 |
| 96 | MAP3K1 | 0.56036612 |
| 97 | STK11 | 0.55185916 |
| 98 | NLK | 0.55072680 |
| 99 | MAPK13 | 0.54776909 |
| 100 | MAP3K8 | 0.54774640 |
| 101 | EEF2K | 0.53793056 |
| 102 | MAP2K4 | 0.53518350 |
| 103 | CDK4 | 0.53300384 |
| 104 | BRSK2 | 0.53081379 |
| 105 | ABL1 | 0.52681491 |
| 106 | MAP2K2 | 0.52391865 |
| 107 | GRK7 | 0.52288406 |
| 108 | CAMK1D | 0.51262877 |
| 109 | YES1 | 0.51259753 |
| 110 | RPS6KA2 | 0.48515476 |
| 111 | EGFR | 0.47671424 |
| 112 | ADRBK1 | 0.46740845 |
| 113 | EIF2AK1 | 0.46658204 |
| 114 | EIF2AK2 | 0.46411055 |
| 115 | BUB1 | 0.43859979 |
| 116 | FYN | 0.43677097 |
| 117 | MAPKAPK2 | 0.43090236 |
| 118 | ATR | 0.42920947 |
| 119 | PRKD2 | 0.42088030 |
| 120 | CHUK | 0.41146687 |
| 121 | ERBB3 | 0.40712721 |
| 122 | MAP3K3 | 0.40477538 |
| 123 | CDK7 | 0.39677782 |
| 124 | ACVR1B | 0.39557248 |
| 125 | PDK1 | 0.39452619 |
| 126 | FGFR3 | 0.39069569 |
| 127 | MAP3K5 | 0.38294717 |
| 128 | ADRBK2 | 0.38177220 |
| 129 | MAP3K6 | 0.38150050 |
| 130 | PTK6 | 0.38051074 |
| 131 | MAPK12 | 0.36875068 |
| 132 | IRAK2 | 0.35283509 |
| 133 | MARK2 | 0.33139552 |
| 134 | TGFBR1 | 0.32884356 |
| 135 | PRKCZ | 0.32717019 |
| 136 | PIK3CG | 0.32237160 |
| 137 | SIK3 | 0.31258973 |
| 138 | MAP3K7 | 0.31149828 |
| 139 | HIPK2 | 0.26719501 |
| 140 | PDPK1 | 0.26324314 |
| 141 | CAMK4 | 0.22362767 |
| 142 | MAPK7 | 0.21992040 |
| 143 | WNK1 | 0.21676291 |
| 144 | IGF1R | 0.21305342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.79445041 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.42131312 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.33467516 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.28029771 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.97049640 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.95059297 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.61693340 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54618659 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.27611014 |
| 10 | Phagosome_Homo sapiens_hsa04145 | 2.23980607 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.17592107 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12953739 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.10009417 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.97361735 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.89558838 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87295284 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86347147 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76309866 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71254570 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69800434 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.61968100 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61209990 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56871841 |
| 24 | Shigellosis_Homo sapiens_hsa05131 | 1.51657100 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.45715174 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43796736 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.40555422 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.40014008 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37879353 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.36105061 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33866669 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33407261 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30750903 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.30608897 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29671103 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27250270 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26899244 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.25766180 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.25122041 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24633102 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24135152 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22259616 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20951492 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15830593 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14423827 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08813535 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06462554 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03553509 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02043128 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.00629313 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98173779 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96711655 |
| 53 | Homologous recombination_Homo sapiens_hsa03440 | 0.96149481 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95265568 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92316470 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91158253 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 0.90670088 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88119946 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87838874 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.87254964 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85693545 |
| 62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.85560810 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84421965 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84403534 |
| 65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84062110 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77443954 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76772413 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75974965 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.75856284 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74047859 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73727500 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73387660 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73302398 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71517014 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71510253 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69307949 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69251678 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67806984 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65492667 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65404304 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.64664612 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64464646 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64411995 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.63706472 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61951939 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61334074 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.58900164 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58475823 |
| 89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58000556 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56328176 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51921028 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51868630 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50088297 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49389523 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48649770 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46958660 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44499837 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43184937 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.43175043 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42239650 |
| 101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41892414 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.41561670 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41256797 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38033280 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36971167 |
| 106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.36922321 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35474608 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.33387238 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33345032 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33217873 |
| 111 | Cell cycle_Homo sapiens_hsa04110 | 0.32280159 |
| 112 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31934691 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31679146 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30467845 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30460021 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30382810 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29734944 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29651908 |
| 119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27558192 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27072386 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26064917 |
| 122 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.25914216 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21045677 |
| 124 | Morphine addiction_Homo sapiens_hsa05032 | 0.20387603 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.20048870 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19366285 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16264443 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.15722535 |
| 129 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13577813 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.12828297 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.12071929 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11187613 |

